HEM1036

· HEM Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HEM1036, covering 2023-05-25 to 2023-05-25. Get the full timeline:

Most recent: Clinical Trial Update: HEM1036 Phase 2 Study in Low Anterior Resection Syndrome [Phase 2]